| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/17/2000 | CN1253179A Structure of antisense oligonucleotide to inhibit activity of telomerase and its application |
| 05/17/2000 | CN1253019A Method for preparing medicine composition capable of inhibiting post infective virus proteinase |
| 05/17/2000 | CN1253018A Nm-class insulin particles and their preparing process |
| 05/17/2000 | CN1052510C Mammalian receptors for interleukin-10 |
| 05/16/2000 | US6063911 Methods and compositions for treatment of cell proliferative disorders |
| 05/16/2000 | US6063910 Bringing droplets of liquid protein solution in a solvent into contact at controlled rate with excess of supercritical antisolvent which dissolves and expands liquid solution and precipitates dry protein particles; for time-release drugs |
| 05/16/2000 | US6063909 Preparation of factor IX |
| 05/16/2000 | US6063907 In vitro methods for determining in vivo thrombotic events |
| 05/16/2000 | US6063906 Antibodies to integrin alpha subunit |
| 05/16/2000 | US6063905 Recombinant human IGA-J. chain dimer |
| 05/16/2000 | US6063903 Ligands for EPH-like receptors |
| 05/16/2000 | US6063902 Amino acid sequence of protein from fleas; for prevention/treatment of allergy dermatitis in animals; antiinflammatory agents; pesticides |
| 05/16/2000 | US6063900 Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof |
| 05/16/2000 | US6063819 Neuroprotective poly-guanidino compounds which block presynaptic N and P/Q calcium channels |
| 05/16/2000 | US6063795 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/16/2000 | US6063794 Selective factor Xa inhibitors |
| 05/16/2000 | US6063772 Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes |
| 05/16/2000 | US6063768 Application of botulinum toxin to the management of neurogenic inflammatory disorders |
| 05/16/2000 | US6063766 Drugs and proteins from blood with amino acid sequences |
| 05/16/2000 | US6063765 Bactericides against gram negative bacteria consiting of proteins |
| 05/16/2000 | US6063764 Method for using lipoprotein associated coagulation inhibitor to treat sepsis |
| 05/16/2000 | US6063763 Enzyme inhibitors |
| 05/16/2000 | US6063762 Cyclosporin microemulsion with oils, solvents and surfactants |
| 05/16/2000 | US6063761 Hepatoselective pharmaceutical actives |
| 05/16/2000 | US6063760 Proteins with amino acid sequences |
| 05/16/2000 | US6063758 Substance P-Saporin (SP-SAP) conjugates and methods of use thereof |
| 05/16/2000 | US6063757 Wound treatment method with nerve growth factor |
| 05/16/2000 | US6063755 Polypeptides with amino acid sequennces encoded by cdna clone |
| 05/16/2000 | US6063626 Antisense inhibition of G-alpha-i3 expression |
| 05/16/2000 | US6063625 Regulated transcription of targeted genes and other biological events |
| 05/16/2000 | US6063623 Transport protein which effects the transport of cationic xenobiotics and/or pharmaceuticals, DNA sequences encoding it and their use |
| 05/16/2000 | US6063621 Hybridoma cell qcrl-1 having atcc accession number hb 11765; for production of monoclonal antibodies for use as antitumor agents and diagnostic reagents |
| 05/16/2000 | US6063620 Type I angiotensin II receptor specific monoclonal antibodies and hybridomas |
| 05/16/2000 | US6063612 Antiviral reagents based on RNA-binding proteins |
| 05/16/2000 | US6063610 Flea hydrolase enzyme; for development of antibodies to prevent parasitic infection of plant and animals |
| 05/16/2000 | US6063609 Expression vector comprising an enzymatic protein; for use as diagnostic tools as well as antiarthritic, antiproliferative, anticarcinogenic, antitumor and antiinflammatory agents |
| 05/16/2000 | US6063606 Nucleotide sequence that codes for a protein that oxides a retinoid; for the treatment of cancer; anticarcinogenic agents |
| 05/16/2000 | US6063600 DNA encoding canine interleukin-1 receptor antagonist |
| 05/16/2000 | US6063599 Nucleic acid sequence of parasite polypeptide; for diagnosis of parasitic helminth infection; for the development of vaccines to prevent helminth and nematode infection |
| 05/16/2000 | US6063596 G-protein coupled receptors associated with immune response |
| 05/16/2000 | US6063594 DNA encoding a novel human anion channel |
| 05/16/2000 | US6063593 TGFβ1 responsive bone marrow derived cells to express a recombinant protein |
| 05/16/2000 | US6063585 Tumor necrosis factor receptor associated factor regulated protein product; for the prevention of tumors cause by epstein barr virus; antitumor agents |
| 05/16/2000 | US6063582 Methods of screening for compounds that interact with human P2u2 purinergic receptor |
| 05/16/2000 | US6063575 Assay for measuring the activity and fidelity of DNA replication and kit therefor |
| 05/16/2000 | US6063566 Enzymatic ribonucleic acid molecule which catalyzes the position preferential cleavage of single-stranded deoxyribonucleic |
| 05/16/2000 | US6063407 Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
| 05/16/2000 | US6063379 Anti-idiotypic monoclonal antibodies and compositions including the anti-idiotypic monoclonal antibodies |
| 05/16/2000 | US6063378 Therapeutic agent for herniated intervertebral disc |
| 05/16/2000 | US6063377 Rho protein |
| 05/16/2000 | US6063376 Human deoxycytidine kinase 2 |
| 05/16/2000 | US6063375 Semiallogeneic cell hybrids and related methods for treating cancer |
| 05/16/2000 | US6063373 Enhanced activation of NK cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor |
| 05/16/2000 | US6063372 Uses of mammalian CTLA-8 and related reagents |
| 05/16/2000 | US6063371 Co-administering interleukins and receptor to mammal |
| 05/16/2000 | US6063370 Drug, polymer complex |
| 05/16/2000 | US6063367 Protein extract from cereal gluten, preparation thereof and use thereof in hair care |
| 05/16/2000 | US6063116 Modulation of cell proliferation and wound healing |
| 05/16/2000 | US6062431 Package for beverages |
| 05/16/2000 | CA2271826A1 Methods and compositions for increasing the infectively of retroviruses |
| 05/16/2000 | CA2170255C Pharmaceutical composition for immunoenhancement therapy |
| 05/16/2000 | CA2113660C Process for the obtention of biological adhesive made of concentrated coagulation factors by salting-out |
| 05/16/2000 | CA2097820C Proteoglycan(g009) effective in enhancing antitumor immunity |
| 05/16/2000 | CA2084060C Combined treatment with gnrh antagonist and gnrh to control gonadotropin levels in mammals |
| 05/16/2000 | CA2053121C Pharmaceutical preparation based on lys-plasminogen |
| 05/16/2000 | CA1340994C Treatment of conditions and disease |
| 05/16/2000 | CA1340992C Process for the production of recombinant porcine growth hormone polypeptides |
| 05/12/2000 | CA2288680A1 Modulation of cell proliferative disorders by cyclic rgd |
| 05/11/2000 | WO2000026418A1 Human pan-hcv human monoclonal antibodies |
| 05/11/2000 | WO2000026395A2 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
| 05/11/2000 | WO2000026394A1 Variants of humanized anti-carcinoma monoclonal antibody cc49 |
| 05/11/2000 | WO2000026380A1 Rotavirus subunit vaccine |
| 05/11/2000 | WO2000026379A2 Polypeptide mediating cell permeability |
| 05/11/2000 | WO2000026377A1 POLYNUCLEOTIDES AND POLYPEPTIDES ENCODING metK ISOLATED FROM $i(STREPTOCCOCCUS PNEUMONIAE) |
| 05/11/2000 | WO2000026376A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026374A2 Adipose specific protein |
| 05/11/2000 | WO2000026372A1 Myosin heavy chain homolog |
| 05/11/2000 | WO2000026368A2 Therapeutic antiangiogenic endostatin compositions |
| 05/11/2000 | WO2000026367A2 Therapeutics and diagnostics for ocular abnormalities |
| 05/11/2000 | WO2000026365A1 NOVEL GENE AND PROTEIN ERRη ENCODED THEREBY |
| 05/11/2000 | WO2000026364A1 Regulator of notch signaling activity |
| 05/11/2000 | WO2000026362A2 Proteins of the stomatin family and their use as target proteins for pain therapy |
| 05/11/2000 | WO2000026360A1 Compounds and methods for modulating claudin-mediated functions |
| 05/11/2000 | WO2000026357A2 Transgenic and cloned mammals |
| 05/11/2000 | WO2000026354A1 Glycosylated proteins having reduced allergenicity |
| 05/11/2000 | WO2000026353A1 Cyclic peptide ligands that target urokinase plasminogen activator receptor, their pharmaceutical compositions and use |
| 05/11/2000 | WO2000026352A1 Novel trypsin family serine proteases |
| 05/11/2000 | WO2000026350A2 Coenzyme a-utilizing enzymes |
| 05/11/2000 | WO2000026348A2 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
| 05/11/2000 | WO2000026342A1 Method of interfering with cell proliferation |
| 05/11/2000 | WO2000026340A2 Novel nucleic acid molecules encoding opioid growth factor receptors |
| 05/11/2000 | WO2000026252A1 Compounds with growth hormone releasing properties |
| 05/11/2000 | WO2000026251A2 A COMPLEX OF A CHAPERONE WITH ss-AMYLOID AND METHODS EMPLOYING THIS COMPLEX |
| 05/11/2000 | WO2000026250A1 HUMAN H37 PROTEINS AND cDNAS ENCODING THE SAME |
| 05/11/2000 | WO2000026249A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 05/11/2000 | WO2000026248A2 Tuberculosis diagnostic test |
| 05/11/2000 | WO2000026247A2 Ikaros isoforms and mutants |
| 05/11/2000 | WO2000026246A2 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |
| 05/11/2000 | WO2000026245A2 Human membrane transport proteins |
| 05/11/2000 | WO2000026244A2 A novel tumor necrosis factor family member, drl, and related compositions and methods |